DocDollars

Greenwich Biosciences, Inc.

CA · United States · Reporting entity ID 100000486813

Total reported 2019–2025
$3.60M
#823 of 2,960 reporting companies — 0% of all reported industry payments
$3.07M in general payments across 15,938 records, plus $530K in research funding across 8 records.

How it breaks down

General payments $3,067,997
Research funding $530,128

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Greenwich Biosciences, Inc. reported $3.60M to US doctors and teaching hospitals from 2019 to 2025, ranking #823 of 2,960 reporting companies. 15% of that was research funding and 85% general payments such as consulting, speaking, food and travel. 15,938 general payment records and 8 research records were filed.

Common questions about Greenwich Biosciences, Inc.

How much has Greenwich Biosciences, Inc. paid US doctors?

Greenwich Biosciences, Inc. reported $3,598,125 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,067,997 in general payments, $530,128 in research funding.

How does Greenwich Biosciences, Inc. rank among drug and device companies?

It ranks #823 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Greenwich Biosciences, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.